Bayer CropScience and FuturaGene sign license agreement for drought tolerance technology in cotton
Bayer CropScience and FuturaGene PLC have entered into a license agreement for a drought tolerance technology. The agreement grants Bayer CropScience exclusive worldwide rights to utilize a FuturaGene drought tolerance technology in cotton. FuturaGene will receive an upfront license fee, followed by development milestone payments and trait royalties on sales of cotton seeds incorporating this technology. Further financial details were not disclosed.
The technology licensed to Bayer is intended to protect the yield of cotton plants when they are subjected to drought. Drought is one of the principal environmental limits of crop yield as it hampers the cultivation of crops on more than 40 percent of the earth’s land surface, posing a serious threat to global agricultural production and food supplies.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

AH diagnostics as - Århus, Denmark

Insect wings inspire new ways to fight superbugs - Scientists reveal how nanomaterials inspired by insect wings are able to destroy bacteria on contact
Anti-gliadin_antibodies
RevaTen platelet-rich plasma shows promise as potential treatment for heart attacks
Generex Biotechnology to begin human trial of avian influenza vaccine
Evotec reaches milestone in integrated drug discovery and development partnership with Aeovian
Bio-molekula new distributor for Carlo Erba Reagents in Germany
Erasing a genetic mutation

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy - Growth through investments in the “Big 3”

A new, highly sensitive chemical sensor uses protein nanowires - UMass Amherst team introduces high-performing 'green' electronic sensor
